BrainScope’s technology in development is based on the premise that the brain electrical activity, whether reflexive, automatic, unconscious or conscious, is electro-chemical in nature, and has mathematically predictable electrical correlates. Through a series of electro-chemical reactions, mediated by molecules called neurotransmitters, electrical potentials (voltages) are generated and transmitted throughout the brain, traveling continuously between and among the myriad of neurons. This activity establishes the basic electrical signatures of the traditional electroencephalogram (EEG) and creates identifiable frequencies based on structure and function and changing predictably as a function of age.
Quantification and analysis of these features provide EEG-based objective descriptors of brain function. Characterization of the EEG as either being within or beyond normal limits is the core capability to assess normal and abnormal brain function, and specifically identify TBI.
BrainScope’s novel application of advanced mathematics and miniaturized hardware is designed to bridge the limitations of traditional EEG tools (bulky, expensive, need expert data interpretation), to provide easy-to-use, non-invasive, timely, point-of-care tools that can assist with an initial assessment of brain function as well as provide adjunctive assessment across the continuum of brain care. BrainScope’s device in development is focused on TBI in military settings, with future uses intended for sports and emergency medicine environments.